References
- Björklund B. On the nature and clinical use of tissue polypep-tide antigen. Tumor Diagn 1980; 1: 9–20
- Björklund B. Overview of TPA: specificity immunochemistry and biological basis. Protides Biol Fluids Proc. Coll., H Peeters. Pergamon Press, Oxford 1984; Vol. 31: 425–36
- Björklund B, Björklund V. Specificity and basis of the tissue polypeptide antigen. Cancer Detect Prev 1983; 6: 41–50
- Nathrath W B, Schuppel R H, Wiebecke B, Björklund B. Distribution of tissue polypeptide antigen (TPA) in normal mu-cosa, in colitis ulcerosa, in adenomas and in carcinomas of the human colorectum. An immunochernical study. APMIS 1988; 96: 509–18
- MenendezBotet C J, Oettgen H F, Pinsky C M, Schwartz M K. A preliminary evaluation of TPA in serum or urine (or both) of patients with cancer or benign neoplasms. Clin Chem 1978; 24: 868–72
- Stahle E, Glimelius B, Bergström R, Påhlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumor stage. Eur J Surg Oncol 1988; 14: 287–96
- Stahle E, Glimelius B, Bergström R, Pahlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis. Eur J Surg Oncol 1988; 14: 277–86
- Buccheri G, Ferrigno D. Usefulness of tissue polypeptide antigen in staging. monitoring, and prognosis of lung cancer. Chest 1988; 93: 565–70
- Panza N, Pacilio G, Campanella L, et al. Cancer antigen 125, tissue polypeptide antigen, carcinoembrionic antigen. and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma. Cancer 1988; 61: 76–83
- Marczynska A, Kulpa J, Lenko J, Augustin M. Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer. Int Urol Nephrol 1988; 20: 123–9
- Nicolini A, Carpi A, Di Marco G, Giuliani L, Giordani R, Palla S. A rational postoperative follow-up with carcinoem-bryonic antigen, tissue polypeptide antigen. and urinary hy-droxyproline in breast cancer patients. Cancer 1989; 63: 2037–46
- Fukazawa I, Inaba N, Ota Y. Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecologic disease. Arch Gynecol Ob-stet 1988; 243: 41–50
- Becciolini A, Tommasi M S, Porciani S, Fantappié B, Cellai E, Chiavacci A. Serum tissue polypeptide antigen (TPA): a marker of acute injury of salivary glands during radiation therapy. Int J Radiat Oncol Biol Phys 1987; 13: 1339–42
- Becciolini A, Giannardi G, Cionini L, Porciani S, Fallai C, Pirtoli L. Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands. Acta Radiol Oncol. 1984; 23: 9–14
- Becciolini A, Porciani S, Lanini A, Chiavacci A, Cellai E. Effect of irradiation with conventional and multiple daily fractionation on serum amylase activity. Acta Oncol. 1987; 26: 139–42
- Dubray B, Girinsky T, Thames H D, et al. Post irradiation hyperamylasemia as a biological dosimeter. Radiother Oncol 1992; 24: 21–6
- International Union Against Cancer (UICC). TNM classification of malignant tumours, P Hermanek, L H Sobin. Springer-Verlag, Berlin 1987; 13–29